Opioid dependence: Detoxification

Similar documents
Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Opioids Research to Practice

Opioids Research to Practice

Clinical Policy: Lofexidine (Lucemyra) Reference Number: ERX.NPA.88 Effective Date:

ROSC & MAT II: Opioid Treatment Services

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Opioids Research to Practice

Module II Opioids 101 Opiate Opioid

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

Opioids Research to Practice

See Important Reminder at the end of this policy for important regulatory and legal information.

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy

Opioids Research to Practice

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Disclosure Statement. Learning Objectives. American Psychiatric Nurses Association. Christian J. Teter, PharmD, BCPP 1 BUPRENORPHINE UPDATE

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Withdrawal.

Treatment Alternatives for Substance Use Disorders

BASIC VOLUME. Elements of Drug Dependence Treatment

Prescription Opioid Addiction

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Substance Use Disorders: What Can We Do to Help Break the Cycle of Addiction

SUBOXONE TREATMENT PROGRAM

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

Opioid Overdose Epidemic A Crises and Opportunity

Opioid dependence and buprenorphine treatment

Medication for the Treatment of Alcohol Use Disorder. Pocket Guide

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

Medication Assisted Treatment. Nicole Gastala, MD

PART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018

Opioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA

Acute General Medical and Surgical Admission:

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Opiate Use Disorder and Opiate Overdose

Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Treatment of Opioid Use Disorder

Treatment of Opioid Use Disorder

MANAGING OPIOID WITHDRAWAL AND OPIOID USE DISORDER (OUD)

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services

Overview of Opioid Use Disorder

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine as a Treatment Option for Opioid Use Disorder

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

Prescribing Framework for Naltrexone in Relapse Prevention (Opioid Dependence)

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

Appendix F Federation of State Medical Boards

Opioid Dependence and Buprenorphine Management

Medication Assisted Treatment. Michael Palladini, RPh MBA CAC

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

CLINICAL PRACTICE GUIDELINES FOR BUPRENORPHINE AND METHADONE BASED OST DR. RAVINDRA RAO ASSISTANT PROFESSOR NDDTC, AIIMS

Long term pharmacotherapy for Alcohol Dependence: Anti Craving agents

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Guidance for naltrexone prescribing

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Medication-Assisted Treatment (MAT) Overview

Treating Opioid Addiction

In 2008, an estimated 282,000 persons

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS LECTURE COVERS. SUDs ARE IMPORTANT. I have nothing to declare

Alternatives to Buprenorphine

Opioid Use in Youth. Amy Yule M.D. March 2,

Optimizing Suboxone in Opioid Addicts

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

VOLUME C. Pharmacological Treatment for Drug Use Disorders Drug Treatment for Special Populations

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

Opioid Replacement Therapy

Dr Chris Ford Clinical Director IDHDP (International Doctors for Healthy Drug Policies) Thursday 16 th May 2013

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Perinatal, Neonatal, Pediatric Conference

MEDICATION ASSISTED ADDICTION TREATMENT: Appropriate Use

GOALS AND OBJECTIVES

Opioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W.

Guidance For The Use Of Lofexidine In The Symptomatic Management Of Opioid Withdrawal By Clinicians Working Within NHS Grampian. Consultation Group:

Opioid Initiative Wave I Treating Opioid-Use Disorder in the ED Part 1

Proposed Revision to Med (i)

WITHDRAWING FROM BUPRENORPHINE THERAPY

Identifying and managing Opioid Use Disorder. Workers Compensation and Auto/No-Fault Continuing Education May 25, 2017

Biological Addictions Treatment. Psychology 470. Many Types of Approaches

Substance Abuse Protracted Withdrawal

Opioids. Sergio Hernandez, MD

Dr. Renner receives honoraria from Reed Medical Education

MAT: The Leader in Assists

Suboxone Addiction & Treatment

Benzodiazepines: risks, benefits or dependence

Ambulatory Intoxication and Withdrawal Management: A Clinical Monograph

Detoxification of Chemically Dependent Inmates Federal Bureau of Prisons Clinical Practice Guidelines August 2009

Naltrexone for Opioid Use Disorder. A Project RAMP Resource Adam J. Gordon, MD MPH FACP DFASAM CMRO December 2017

Transcription:

Opioid dependence: Detoxification

What is detoxification? A. Process of removal of toxins from the body? B. Admitting a drug dependent person in a hospital and giving him nutrition? C. Stopping drug use and providing treatment for withdrawal symptoms? D. Gradual reduction of drug use by the patient?

Introduction o Detoxification: a process where a individual who is physically dependent on a drug is taken off the drug either abruptly or gradually. o Purpose: minimize subjective and objective discomfort

Introduction o Detoxification: Initial Phase of treatment of substance dependence. o Includes- treatment of withdrawal symptoms. Assessment of health and psychosocial complications Building therapeutic relationship. o Pharmacotherapy has a primary role in this phase of treatment.

Methods 1. Gradual reduction of the substance in decreasing amounts 2. Abrupt cessation, AND : a. Use of a drug pharmacologically similar to the substance on which the person is dependent, in particular one which produces cross tolerance. b. Use of a drug which affects the mechanisms whereby withdrawal is experienced. c. Symptomatic treatment to alleviate symptoms of withdrawal. Abrupt total cessation of the primary drug and treatment of withdrawal is a widely accepted method.

What kind of medications are suitable for detoxification? o Characteristics of a good agent for treatment of opioid withdrawals Treat withdrawals Longer acting Safe Cross tolerance Less dependence potential Easily available

Dose of medicines for detoxification Depends upon According to substance used. Potency, half life Time elapsed since the last dose Severity of dependence Duration of consumption, route of administration etc Concomitant use of other drugs Presence of general medical or psychiatric disorder. Individual biological and psychological variables.

Dose of medicines for detoxification Goal Make the experience of withdrawal tolerable rather than suppress all symptoms. Modify dosage according to assessment of withdrawal symptoms. Least possible amount of medicine for the shortest period of time

Setting o Indications for outpatient treatment. Mild or moderate dependence No previous treatment attempts Good social support system Absence of significant health damage Geographical proximity

Setting o Indications for inpatient treatment Severe withdrawal states, multiple drug use Medical complications/obvious psychopathology Geographical distance Failure of outpatient treatment Parenteral drug use pattern/ intoxicated states Crisis in social support system Academic and research reasons Multiple drug abuse.

Opiate Detoxification o Goals Ridding the body of acute physiological dependence. Diminishing pain and discomfort. Treating any medical problems discovered or making appropriate referrals. Beginning the process of educating the patient about issues related to health and relapse prevention Exploring issues such as family, vocational and legal problems that may need referral.

Factors Influencing Symptom severity 1. Specific Drug used. 2. Total Daily amount used. 3. Duration and regularity of use 4. Psychological factors

Signs and Symptoms of opiate withdrawal o Aching of bones and muscles o Anxiety, Dysphoria, Restlessness and broken sleep o Craving o Yawning, Lacrimation, Rhinorrhea,. o Pupillary dilatation o Nausea, vomiting, diarrhoea, abdominal cramps, o Goose flesh Opening of all holes of the body

Guidelines 1. Rely on objective signs and determine severity of withdrawal. 2. Identify drug of abuse, dose, duration, route of administration and last dose. 3. Monitor vital signs. 4. Maintain fluid and electrolyte intake 5. Reassure the patient. 6. Start appropriate drug treatment. 7. Screen urine for illicit drug use (if available) 8. Assess and treat associated medical problems.

Pharmacotherapy o In clinical practice commonly used medications are: Buprenorphine Dextropropoxyphene o Dose: titrated according to clinical symptoms. Tab buprenorphine (S/l): 1.2-6mg in divided dose Cap Propoxyphene 6-12caps, in 3 divided doses. o Duration: 7-10 days and to be tapered between 11-15 days. o Others: Hypnotics, Antidiarrhoeal, NSAIDs

Typical prescription o T. Buprenorphine (0.4 mg) 3 3 3 Or o Cap Proxyvon 3 3 3 o T. Diazepam 5 mg 4 HS o T. Brufen 1 SOS X 7 days

Other Approaches o Clonidine, an ά-2 adrenergic agonist o Dose range: 0.2 mg/day. o NOT RECOMMENDED for OUTPATIENT BASIS: adverse side effects - Hypotension and sedation. o Does not block all withdrawal symptoms: Muscle aching and insomnia are not relieved. o Naltrexone in combination with clonidine: A more rapid method of detoxification: less than 72 hours The former precipitating opioid withdrawal while the latter blocks at least some of the symptoms.

Other Approaches o Auricular acupuncture: Electro-acupuncture involves small amount of electricity to needles inserted on points on external ear for opioid detoxification.

Other forms of detoxification Ultra Rapid Opioid Detoxification o Since 1970s: attempts to shorten the opiate withdrawal by clonidine and opiate antagonists o Shorten the detoxification process to 6-8 hours by precipitating withdrawal by opioid antagonists under general anaesthesia / deep sedation

Other forms of detoxification Ultra Rapid Opioid Detoxification Advantages o Rapidity Disadvantages o Morbidity / mortality o Cost o Ethical issues o No evidence of greater long-term benefits Most Guidelines, do not recommend it / recommend it for a selected patient sub-group

Protracted withdrawal o Management of protracted withdrawal takes longer duration Weeks to months Various non pharmacological methods like relaxation therapy, CBT may need to be used.

Conclusion o Detoxification can take place either in the inpatient or outpatient settings depending on the patient s clinical needs and other psychosocial factors. o An accurate and competent clinical assessment is essential when detoxification and subsequent treatment plans are formulated.

Conclusion o Opiate withdrawal is not life threatening, but uncomfortable o Achievement of a substance free state is preparatory for the more challenging but also more rewarding period of sustained abstinence.